greeksoup/ stock research
Stock research / United States / JNJ / FY2007

Johnson & Johnson (JNJ) FY2007 results: revenue $61.1 billion

Johnson & Johnson (JNJ) reported revenue of $61.1 billion for fiscal 2007, the year ended 30 December 2007. Net income was $10.6 billion, and diluted earnings per share $3.63. The figures are the company's own, from the 10-K it filed with the SEC on 1 March 2010.

Revenue
$61.1 billion
FY2007FY2007
Operating margin
n/a
FY2007FY2007
Net income
$10.6 billion
FY2007FY2007
Diluted EPS
$3.63
FY2007FY2007

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2007Last 8 years
Revenue61,095
Cost of revenue17,751
Gross profit43,344
Gross margin70.9%
Research and development7,680
Selling, general and administrative20,451
Interest expense296
Pre-tax income13,283
Income tax2,707
Effective tax rate20.4%
Net income10,576
Net margin17.3%
Diluted EPS$3.63
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2007Last 8 years
Operating cash flow15,022
Capital expenditure2,942
Free cash flow12,080
Free cash flow margin19.8%
Cash from investing-5,912
Cash from financing-5,698
Depreciation and amortisation2,777
Share-based compensation698
Buybacks5,607
Dividends paid4,670
Dividend per share$1.62
Diluted shares, weighted2,911m

Balance sheet

$ millionFY2007Last 8 years
Shareholders' equity43,319
Cash and equivalents7,770

10-K for the year ended 30 December 2007, filed 1 March 2010: the filing.